Ledger.Open graph →
SEC Form D · Amendment · filed February 7, 2019

Abrexa Pharmaceuticals, Inc

Offering
$16.6M
Sold
$16.6M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
SAN DIEGO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

James J. Truchard · San Diego, CADirectorDavid J. Hugley · San Diego, CADirectorJ. E. Villafranca · San Diego, CAExec · DirectorKathryn Fantauzzi · Pittsburgh, PADirectorRichard J. Walters Ii · New York, NYExec · DirectorJack A. Theeler · Mitchell, SDDirectorJay Manni · San Jose, CAExec · DirectorDavid J. Hugley · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗